Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Share-based Compensation (2021 - 2025)

Historic Share-based Compensation for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to $436884.0.

  • HeartSciences' Share-based Compensation rose 88041.79% to $436884.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $762211.0, marking a year-over-year increase of 18071.38%. This contributed to the annual value of $249884.0 for FY2025, which is 3830.41% down from last year.
  • As of Q4 2025, HeartSciences' Share-based Compensation stood at $436884.0, which was up 88041.79% from $174558.0 recorded in Q3 2025.
  • HeartSciences' Share-based Compensation's 5-year high stood at $436884.0 during Q4 2025, with a 5-year trough of -$49853.0 in Q2 2022.
  • For the 5-year period, HeartSciences' Share-based Compensation averaged around $87947.4, with its median value being $82668.5 (2024).
  • In the last 5 years, HeartSciences' Share-based Compensation soared by 895668.12% in 2022 and then plummeted by 9869.38% in 2023.
  • Over the past 5 years, HeartSciences' Share-based Compensation (Quarter) stood at $808.0 in 2021, then soared by 137.38% to $1918.0 in 2022, then skyrocketed by 5529.2% to $107968.0 in 2023, then tumbled by 58.73% to $44561.0 in 2024, then skyrocketed by 880.42% to $436884.0 in 2025.
  • Its last three reported values are $436884.0 in Q4 2025, $174558.0 for Q3 2025, and $95945.0 during Q2 2025.